Your browser doesn't support javascript.
loading
Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus-based cervical screening program: A cross-sectional survey.
Chadwick, Verity; Bennett, Kirsty F; McCaffery, Kirsten J; Brotherton, Julia M L; Dodd, Rachael H.
Afiliação
  • Chadwick V; Royal North Shore Hospital, St Leonards, New South Wales, Australia.
  • Bennett KF; Department of Behavioural Science and Health, Cancer Communication and Screening Group, University College London, London, UK.
  • McCaffery KJ; Faculty of Medicine and Health, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Brotherton JML; VCS Population Health, VCS Foundation, Carlton South, Victoria, Australia.
  • Dodd RH; Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia.
Psychooncology ; 31(7): 1110-1119, 2022 07.
Article em En | MEDLINE | ID: mdl-35128756
ABSTRACT

OBJECTIVE:

To examine the impact of self-reported human papillomavirus (HPV) test result (HPV negative, HPV positive, HPV result unknown) on a range of psychosocial outcomes.

METHODS:

Women and other people with a cervix in Australia aged 25-74 years who reported having participated in cervical screening since December 2017 were recruited through Facebook and Instagram to complete an online survey. The primary outcome measures were anxiety, emotional distress, and general distress.

RESULTS:

Nine hundred fifteen participants completed the online survey; 73.2% reported testing HPV negative ('HPV-'), 15% reported testing HPV positive ('HPV+') and 11.8% reported that they did not know/remember their test result ('HPV unknown'). Compared to participants testing HPV-, participants testing HPV+ had higher mean anxiety (41.67 vs. 37.08, p < 0.001) and emotional distress scores (11.88 vs. 7.71, p < 0.001). Concern about test result (34.3% vs. 1.3%, p < 0.001), perceived risk compared to average women (55.4% vs. 14.1%, p < 0.001), and cancer worry (27.8% vs. 5.9%, p < 0.001) were also greater among HPV+ participants than participants testing HPV-. Participants testing HPV+ felt less reassured about their screening result than participants testing HPV- (16% vs. 75.1%, p < 0.001). Participants testing HPV+ had greater knowledge of HPV (11.96 vs. 10.36 out of 16, p < 0.001) and HPV testing (3.94 vs 3.28 out of 5, p < 0.001) than participants who reported testing HPV-.

CONCLUSIONS:

Elevated levels of anxiety and emotional distress were found in those testing HPV+ compared with those testing HPV-. Future research should examine what strategies should be used to deliver test results and what additional information is provided, in order to alleviate anxiety among individuals testing HPV+.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus / Alphapapillomavirus Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Psychooncology Assunto da revista: NEOPLASIAS / PSICOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus / Alphapapillomavirus Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Psychooncology Assunto da revista: NEOPLASIAS / PSICOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
...